Erlotinib cancer drug molecule

Erlotinib cancer drug molecule

A624/0476 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.3MB

Downloadable file size: 559.5KB

Price image Pricing

Please login to use the price calculator


Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Erlotinib cancer drug, Computer model of a molecule of the cancer drug erlotinib. Atoms are represented as spheres and are colour-coded: carbon (yellow), hydrogen (white), oxygen (pink) and nitrogen (green). This drug, which is marketed as Tarceva, is used to treat non-small cell lung cancer and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors. These drugs bind to tyrosine kinase growth factor receptors on the cancer cell's surface, inactivating them and so stopping cell growth and proliferation.

Release details: Model release not required. Property release not required.

Keywords: anti-cancer, ball and stick, ball-and-stick, biochemical, biochemistry, chemical, chemistry, chemotherapy, compound, compounds, drug, erlotinib, medical, medicine, molecular, molecular model, molecule, molecules, non-small cell lung cancer, oncology, one, pancreatic cancer, pharmaceutical, pharmaceutics, pharmacological, pharmacology, single, structure, tarceva, tyrosine kinase inhibitor

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.